Healthtech Startups

Gutcrine is a Danish biotech developing pharmabiotics derived from gut microbiome hormone synthesis, aimed at the prevention and treatment of cardio-metabolic disorders.

1 investor

Resilience Gastroenterology provides remote monitoring software for patients with chronic inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis. The platform delivers personalized patient follow-up, clinical decision support through electronic patient-reported outcomes and biomarker integration, and supports gastroenterology teams with structured alerts and care coordination.

1 investor

GXP-Storage provides GxP-compliant regulated materials storage and lifecycle management for life sciences organizations across pre-clinical research, clinical trials, commercial manufacturing, and healthcare delivery. Its GXP-Guardian platform combines physical material records and secure e-archives into a single inspection-ready archive, serving life sciences sectors in the US and UK.

1 investor

Gyala Therapeutics develops autologous immunotherapy based on CAR-T technology targeting CD84 for cancer treatment. The company is a technology-based enterprise supported by Spanish government research and innovation programs.

1 investor

Gylden Pharma develops proprietary dermal delivery platforms for therapeutic medicines, using titanium microneedles and programmable gold nanoparticles to enable rapid, precise drug delivery through the skin. The company focuses on oncology and infectious disease applications including tumor immunotherapy and vaccine development.

1 investor

Bridge Innovations works across the medical device business, including product development, manufacturing, intellectual property, regulatory, reimbursement, and commercialization. It draws on a network of advisors, key opinion leaders, product development and manufacturing partners, and industry connections.

1 investor

Gyre Therapeutics is a biopharmaceutical company developing small-molecule therapeutics for organ fibrosis and inflammatory diseases, with its lead program F351 in clinical evaluation for liver fibrosis in the US and China. The company also operates Cullgen Inc., a subsidiary focused on targeted protein degrader therapies for cancer and inflammatory conditions.

1 investor

Gyroid Photonics is a spin-off from a laser spectroscopy research group at IISc, developing photonics technology with applications spanning physics, chemistry, materials, and medicine. The company draws on academic research and holds US and Indian patents.

1 investor

Gyros Protein Technologies develops the Gyrolab platform, an immunoassay solution for bioprocess applications in the biotechnology industry. The platform enables automated protein analysis and characterization for biopharmaceutical development and manufacturing.

1 investor

H-Trace provides artificial intelligence-powered traceability monitoring for healthcare supply chains, using proprietary contactless sensor technology to predict and prevent shipment failures without requiring manual intervention or package opening. The platform serves clinical laboratories, pharmaceuticals, clinical research organizations, and logistics providers.

1 investor

H1 operates an AI-powered platform that identifies and engages healthcare providers, offering data and analytics across clinical trials, medical affairs, commercial engagement, and health plans. It serves life sciences companies, payers, providers, and digital health organizations globally.

1 investor

Habbie is a digital service for rehabilitation, habilitation, and preventive training, providing a virtual physiotherapist that guides patients through individualized exercise sessions with video guidance and feedback options. It also offers healthcare providers an administrative interface to set up training programs and monitor patient progress, with all operations hosted in Sweden.

1 investor

Habbit Apex is a whey protein isolate supplement designed for fitness performance and muscle recovery. The product targets fitness enthusiasts and health-conscious consumers seeking to meet daily protein nutritional goals.

1 investor

Habitat Health operates PACE (Program of All-Inclusive Care for the Elderly) centers offering medical care, social services, home care, and transportation for adults age 55 and older. It serves seniors in Sacramento and South Los Angeles, California.

1 investor

Hackensack Meridian Health is New Jersey's largest health network operating 18 hospitals and over 500 patient care locations, delivering clinical care, medical research, and physician education to improve health outcomes. The organization serves communities across New Jersey with a team of over 41,000 healthcare professionals including nurses, employed physicians, and affiliated physicians.

1 investor

Haemanthus is developing molecular-level diagnostic technology aimed at reading comprehensive molecular health data to detect disease earlier.

1 investor

Hairstetics is a medical device company developing synthetic hair implants for treating hair loss, particularly in women. The procedure involves injecting personalized synthetic hair grafts under local anesthesia, with results visible immediately and minimal recovery time.

1 investor

Hakeem Health operates a telepharmacy platform licensed in the UAE that combines clinical decision support software and pharmacy services. The company serves healthcare professionals and patients with evidence-based diagnostic insights and remote pharmacy care.

1 investor

Hale is a personal care platform for men that provides clinician-informed, unbiased product recommendations based on a user's individual needs. It curates and vets grooming and skincare products—covering face, hair, beard, body, fragrance, and dental care—using a medical advisory board and a standardized filtering process.

1 investor

Hale Animal Health develops novel veterinary pharmaceuticals for companion animals, focused on treatments intended to be effective and safe with fewer side effects. The company targets the pet health market.

1 investor

Hale is an Italian women's health service focused on pelvic pain conditions such as endometriosis, vulvodynia, and painful intercourse, offering a hybrid model of online gynecological consultations and in-person visits with a multidisciplinary team. It provides diagnosis support, personalized treatment plans, second opinions, and a network of affiliated labs, with in-person care available in cities including Turin, Milan, Rome, Verona, Bolzano, Catania, and L'Aquila.

1 investor

HALEO provides therapist-led cognitive behavioural therapy for insomnia (CBT-I), including a proprietary program for shift workers, delivered as a structured 5-6 week program with licensed therapists. The company offers a sleep-health assessment and personalized program recommendations for people struggling with insomnia and sleep disorders.

1 investor

Halex Istar develops, manufactures, and sells ready-to-use injectable medications and large- and small-volume parenteral solutions for the hospital segment. Founded in 1959, the Brazilian pharmaceutical company serves clients nationwide and invests in R&D for incremental innovation in hospital care.

1 investor

Hallam Medical provides specialist healthcare workforce solutions, supplying clinicians to healthcare organizations. The company operates as a healthcare staffing and recruitment firm.

1 investor